Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease.
| Author | |
|---|---|
| Abstract | :
Fibroblast growth factor-21 (FGF-21) is a metabolic regulator with beneficial effects on glucolipid metabolism. Since FGF-21 has lipid-lowering, anti-inflammatory and anti-oxidant properties, it may play a protective role against atherosclerosis. However, blood FGF-21 levels in coronary artery disease (CAD) or peripheral artery disease (PAD) have not been elucidated. |
| Year of Publication | :
2018
|
| Journal | :
Journal of atherosclerosis and thrombosis
|
| Date Published | :
2018
|
| ISSN Number | :
1340-3478
|
| URL | :
https://dx.doi.org/10.5551/jat.41731
|
| DOI | :
10.5551/jat.41731
|
| Short Title | :
J Atheroscler Thromb
|
| Download citation |